RACHEL KNAFEL: Open Payments
NPI 1760848451 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 16 payments from 11 companies in 2025. Trend: 2023 $116 · 2024 $67 · 2025 $473
Food & beverage: $454Education: $19
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $149 |
| Insulet Corporation | 2 | $123 |
| Abbott Laboratories | 2 | $40 |
| BETA BIONICS, INC. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $27 |
| Lilly USA, LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Korlym, Omnipod, JARDIANCE, FREESTYLE LIBRE 3, iLet Bionic Pancreas, Veozah, Auvelity, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
